Brady Chin | Healthy Seminars

Brady Chin

Current Advances in Integrative Reproductive Medicine and Women's Health - Distance Education

Please login or register to take this course.
Distance
Current Advances in Integrative Reproductive Medicine and Women's Health
CTCMA; 7 CEU, Category A2 - AACMA: 7 CPD points allocated
NCCAOM 553-486; 5.0 AOM-AC, 2.0 AOM-BIO
California 591, 7.0 CEU Category 1 - Texas CAE00011; 5 AC CAE, 2 BIO CAE
Illinois (225.000020) 7 CEU - Massachusetts (7 GEN)
ABORM 7 CEU Renewal - Alberta CAAA; 7 CEU - NZRA; 7 CEU
Florida 50-8743; 20-628278; 5 GEN, 2 BIO

Brady Chin

Image of Brady Chin
Brady Chin

Brady Chin is the Dean of the MATCM program at Yo San University, and is in charge of all academic aspects of the Master’s degree program. Brady has over twenty years of experience in Chinese medicine, qigong and martial arts. He graduated from Samra University and had previously served in various administrative roles in other TCM schools in the Los Angeles area. An active member of the acupuncture profession, Brady was a past President of the California Society of Oriental Medicine & Acupuncture (CSOMA).

Current Advances in Integrative Reproductive Medicine and Women's Health

NCCAOM Details
553-486
Send Updated NCCAOM Certificate
Send NCCAOM Certificate
01-08-2018 through 01-31-2020
$175.00
Price: $175.00
Content included with this product.
ItemDetailsAvailableDuration
Current Advances in Integrative Reproductive Medicine and Women's Healthimmediately after purchaseuntil 01/28/2020 - 15:56
California
Category 1
Pending: 

Yo San University (YSU) of Traditional Chinese Medicine is pleased to announce the 2018 YSU Integrative Reproductive Medicine Symposium.

This 1-day symposium will showcase the work of leaders in the area Integrative Reproductive Medicine, highlighting the latest advances, practices, and challenges.

Current Advances in Integrative Reproductive Medicine and Women's Health

The topics to be included are:

The objectives of this full-day seminar are:

1. To provide an update on current clinical practices and integrative management of select conditions in Reproductive Medicine and Women's Health, including, Menopause, Polycystic Ovarian Syndrome (PCOS), common gynecological malignancies as well as general fertility care.

2. Provide acupuncturists with practical clinical knowledge on how acupuncture/ TCM can be integrated into the care of patients with the above-mentioned select conditions.

3. Provide acupuncturists with insight on the role of acupuncture/TCM in optimizing pregnancy rates and the future of integrative fertility care.

830-930   The Future of Integrative Fertility Care, Richard Marrs, M.D.

930-1030   Optimizing Pregnancy Rates in Women of Advancing Reproductive Age, Richard Buyalos, M.D.

1030-1130    TCM Integration into Reproductive Medicine & Fertility Care, Daoshing Ni, Ph.D., L.Ac.

1130-1215    Fertility Achieved! Success Stories and Experiences from Patients and Practitioners, Panel Discussion

1215-115   Lunch break

115-200   Integrative Reproductive Medicine Research: Highlights of YSU DAOM Dissertations in Integrative Reproductive Medicine, Panel Discussion

200-300   Perspectives on Male Fertility Care, Paul Turek, M.D.

300-400   Enhancing Ovulatory Function & Fertility in Polycystic Ovary Syndrome with TCM, Shiaoting Jing, Ph.D., L.Ac.

400-500   Integrative Anti-Aging Approach to Enhancing Fertility, Mao Shing Ni, Ph.D., L.Ac.

D7 Presenter: 
Richard Buyalos
Laraine Crampton
Brady Chin
Richard Marrs
Mao Shing Ni
Paul Turek
Shiaoting Jing
Dr. Daoshing Ni

Current Advances in Integrative Reproductive Medicine and Women's Health

Please login or register to take this course.
Live
Current Advances in Integrative Reproductive Medicine and Women's Health
Sun, 01/28/2018
CTCMA; 7 CEU, Category A2 - AACMA: 7 CPD points allocated
NCCAOM 553-485; 5.0 AOM-AC, 2.0 AOM-BIO
California 591, 7.0 CEU Category 1 - Texas CAE00011; 5 AC CAE, 2 BIO CAE
Illinois (225.000020) 7 CEU - Massachusetts (7 GEN)
ABORM 7 CEU Renewal - Alberta CAAA; 7 CEU - NZRA; 7 CEU
Florida 50-8743; 20-628278; 5 GEN, 2 BIO